Dune Medical Devices Ltd. Release: Marginprobe® Data Presented At San Antonio Breast Cancer Symposium

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

WESTBOROUGH, Mass., Jan. 6, 2014 (GLOBE NEWSWIRE) -- Results of the MarginProbe pivotal study were presented during the 2013 CTRC-AACR San Antonio Breast Cancer Symposium. The results were presented by Dr. Mark Gittleman, Past President of the American Society of Breast Surgeons. The study reports an analysis of the benefit along a range of what constitutes a positive margin following breast cancer lumpectomy surgery, from 0 to 5 millimeters. Independent of how positive margins were defined, adjunctive use of the MarginProbe offered surgeons a significant improvement in the ability to identify and resect positive margins.

Help employers find you! Check out all the jobs and post your resume.

MORE ON THIS TOPIC